![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MXRA5 |
Gene summary for MXRA5 |
![]() |
Gene information | Species | Human | Gene symbol | MXRA5 | Gene ID | 25878 |
Gene name | matrix remodeling associated 5 | |
Gene Alias | MXRA5 | |
Cytomap | Xp22.33 | |
Gene Type | protein-coding | GO ID | GO:0008150 | UniProtAcc | Q9NR99 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
25878 | MXRA5 | LZE8T | Human | Esophagus | ESCC | 8.06e-04 | 1.35e-01 | 0.067 |
25878 | MXRA5 | LZE20T | Human | Esophagus | ESCC | 2.73e-03 | 2.06e-01 | 0.0662 |
25878 | MXRA5 | P5T-E | Human | Esophagus | ESCC | 5.64e-05 | 3.91e-01 | 0.1327 |
25878 | MXRA5 | P8T-E | Human | Esophagus | ESCC | 5.17e-13 | 5.56e-01 | 0.0889 |
25878 | MXRA5 | P9T-E | Human | Esophagus | ESCC | 7.09e-07 | 5.17e-01 | 0.1131 |
25878 | MXRA5 | P10T-E | Human | Esophagus | ESCC | 1.10e-18 | 5.46e-01 | 0.116 |
25878 | MXRA5 | P11T-E | Human | Esophagus | ESCC | 3.35e-21 | 1.14e+00 | 0.1426 |
25878 | MXRA5 | P12T-E | Human | Esophagus | ESCC | 1.12e-11 | 3.75e-01 | 0.1122 |
25878 | MXRA5 | P15T-E | Human | Esophagus | ESCC | 2.50e-06 | 4.52e-01 | 0.1149 |
25878 | MXRA5 | P21T-E | Human | Esophagus | ESCC | 3.89e-07 | 2.54e-01 | 0.1617 |
25878 | MXRA5 | P32T-E | Human | Esophagus | ESCC | 2.29e-02 | 3.35e-01 | 0.1666 |
25878 | MXRA5 | P36T-E | Human | Esophagus | ESCC | 2.00e-05 | 5.52e-01 | 0.1187 |
25878 | MXRA5 | P42T-E | Human | Esophagus | ESCC | 3.30e-03 | 4.91e-01 | 0.1175 |
25878 | MXRA5 | P44T-E | Human | Esophagus | ESCC | 1.02e-11 | 9.87e-01 | 0.1096 |
25878 | MXRA5 | P47T-E | Human | Esophagus | ESCC | 3.74e-10 | 6.79e-01 | 0.1067 |
25878 | MXRA5 | P54T-E | Human | Esophagus | ESCC | 4.50e-05 | 1.45e-01 | 0.0975 |
25878 | MXRA5 | P61T-E | Human | Esophagus | ESCC | 4.08e-33 | 1.59e+00 | 0.099 |
25878 | MXRA5 | P62T-E | Human | Esophagus | ESCC | 1.48e-05 | 1.68e-01 | 0.1302 |
25878 | MXRA5 | P65T-E | Human | Esophagus | ESCC | 1.49e-04 | 2.78e-01 | 0.0978 |
25878 | MXRA5 | P79T-E | Human | Esophagus | ESCC | 6.28e-13 | 4.43e-01 | 0.1154 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00715599 | Esophagus | ESCC | response to transforming growth factor beta | 157/8552 | 256/18723 | 2.95e-07 | 4.23e-06 | 157 |
GO:00715598 | Oral cavity | OSCC | response to transforming growth factor beta | 140/7305 | 256/18723 | 2.34e-07 | 3.70e-06 | 140 |
GO:00715597 | Prostate | BPH | response to transforming growth factor beta | 76/3107 | 256/18723 | 1.14e-07 | 2.73e-06 | 76 |
GO:007155915 | Prostate | Tumor | response to transforming growth factor beta | 76/3246 | 256/18723 | 6.86e-07 | 1.40e-05 | 76 |
GO:007155917 | Skin | cSCC | response to transforming growth factor beta | 95/4864 | 256/18723 | 5.21e-05 | 5.31e-04 | 95 |
GO:007155919 | Thyroid | PTC | response to transforming growth factor beta | 131/5968 | 256/18723 | 9.20e-11 | 3.17e-09 | 131 |
GO:007155925 | Thyroid | ATC | response to transforming growth factor beta | 142/6293 | 256/18723 | 4.30e-13 | 1.94e-11 | 142 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MXRA5 | SNV | Missense_Mutation | c.131N>A | p.Arg44Gln | p.R44Q | Q9NR99 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MXRA5 | SNV | Missense_Mutation | novel | c.6407N>G | p.Gln2136Arg | p.Q2136R | Q9NR99 | protein_coding | tolerated(0.21) | benign(0.026) | TCGA-AJ-A3OJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
MXRA5 | SNV | Missense_Mutation | novel | c.5072N>T | p.Arg1691Ile | p.R1691I | Q9NR99 | protein_coding | tolerated(0.1) | benign(0.021) | TCGA-AJ-A5DW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MXRA5 | SNV | Missense_Mutation | c.2806C>T | p.His936Tyr | p.H936Y | Q9NR99 | protein_coding | tolerated(0.18) | benign(0) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MXRA5 | SNV | Missense_Mutation | novel | c.1580A>C | p.Asp527Ala | p.D527A | Q9NR99 | protein_coding | deleterious(0.03) | benign(0.096) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MXRA5 | SNV | Missense_Mutation | c.246G>T | p.Glu82Asp | p.E82D | Q9NR99 | protein_coding | deleterious(0.01) | probably_damaging(0.97) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MXRA5 | SNV | Missense_Mutation | c.2116N>T | p.Asp706Tyr | p.D706Y | Q9NR99 | protein_coding | deleterious(0.01) | possibly_damaging(0.564) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MXRA5 | SNV | Missense_Mutation | rs750435031 | c.1414N>T | p.Arg472Trp | p.R472W | Q9NR99 | protein_coding | deleterious(0) | possibly_damaging(0.548) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MXRA5 | SNV | Missense_Mutation | c.6951N>T | p.Arg2317Ser | p.R2317S | Q9NR99 | protein_coding | tolerated(0.18) | possibly_damaging(0.908) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
MXRA5 | SNV | Missense_Mutation | c.6173N>T | p.Ser2058Leu | p.S2058L | Q9NR99 | protein_coding | deleterious(0) | probably_damaging(0.966) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |